Ryman Healthcare Ltd (FRA:RH7)
€ 2.162 0.06 (2.85%) Market Cap: 1.45 Bil Enterprise Value: 2.88 Bil PE Ratio: 520.00 PB Ratio: 0.57 GF Score: 62/100

Half Year 2021 Ryman Healthcare Ltd Earnings Call Transcript

Nov 19, 2020 / 09:00PM GMT
Release Date Price: €8.68 (-3.06%)
David Kerr
Ryman Healthcare Limited - Independent Chairman of the Board

(foreign language). Good morning, everyone, and welcome to Ryman Healthcare's First Half Results Presentation. My name is David Kerr, and I'm the Chairman of Ryman Healthcare. To my right, we have Gordon MacLeod, our Chief Executive; and David Bennett, our Chief Financial Officer. We've opted to make our half year presentation a virtual event again. We find this as the best approach when we're planning this announcement because it takes the guesswork out of which COVID level we are in. Of course, being virtual doesn't mean there will not be plenty of opportunity to ask questions. (Operator Instructions)

I'm going to give you a brief overview of the first half, an update on the COVID pandemic from our point of view; Gordy will give you his analysis of the half and thoughts on what he sees ahead, and what we plan to achieve; David will then give you some greater detail on our financial results. At the end of the presentation, we'll then open the session up for questions. (Operator Instructions)

Well, another eventful

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot